SERVIER

We are an independent company dedicated to advancing therapeutic options to meet patient needs.

Founded 70 years ago with the goal of improving health, Servier is a global pharmaceutical company managed by a non-profit foundation, with the goal of making a significant social impact, both for patients and for a sustainable world. With a unique management model, it can fully fulfill its mission with a long-term vision: a commitment to therapeutic progress in order to meet the needs of patients. The company's employees are fully committed to this common mission, which inspires them every day.

Servier is a world leader in the field of cardiometabolism and venous disease and has made significant progress in the field of oncology. The company invests almost 70% of its research and development budget in this area, with the ambition to become an innovative partner, focusing on the treatment of difficult-to-treat cancers. Neurology will be another important direction of growth in the future. The company Servier focuses on a limited number of diseases, where the accurate determination of patient profiles enables the provision of targeted therapeutic solutions through medicine adapted to individual needs.

To provide access to quality healthcare at more affordable prices, the company offers a wide range of high-quality generic medicines covering most diseases, relying on strong brands in France, Eastern Europe and Brazil.

Headquartered in France, Servier relies on a strong geographic presence in nearly 140 countries with revenues of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%).